Mitochondria-targeted nitroxides exacerbate fluvastatin-mediated cytostatic and cytotoxic effects in breast cancer cells

摘要

Mito-CP 11, a mitochondria-targeted nitroxide formed by conjugating a triphenylphosphonium cation to a five-membered nitroxide, carboxy-proxyl (CP), has been used as a superoxide dismutase (SOD) mimetic. In this study, we investigated the antiproliferative and cytotoxic properties of submicromolar levels of Mito-CP 11 alone and in combination with fluvastatin, a well known cholesterol lowering drug, in breast cancer cells. Mito-CP 11, but not CP or CP plus the cationic ligand, methyl triphenylphosphonium (Me-TPP +), inhibited MCF-7 breast cancer cell proliferation. Mito-CP 11 had only minimal effect on MCF-10A, non-tumorigenic mammary epithelial cells. Mito-CP 11, however, significantly enhanced fluvastatin-mediated cytotoxicity in MCF-7 cells. Mito-CP 11 alone and in combination with fluvastatin inhibited nuclear factor kappaB (NFκB) activity mainly in MCF-7 cells. We conclude that mitochondria-targeted nitroxide antioxidant molecules (such as Mito- CP 11) that are non-toxic to non-tumorigenic cells could enhance the cytostatic and cytotoxic effects of statins in breast cancer cells. This strategy of combining mitochondria-targeted non-toxic molecules with cytotoxic chemotherapeutic drugs may be successfully used to enhance the efficacy of antitumor therapies in breast cancer treatment.